Qian Chu
Clinical trials sponsored by Qian Chu, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Data model aims to predict lung cancer therapy outcomes Results expected Oct 2026 (estimated)
-
New combo aims to boost survival in aggressive lung cancer
Disease control Recruiting nowThis phase II trial is testing whether adding the immunotherapy drug durvalumab to standard chemotherapy and radiation can help people with limited-stage small-cell lung cancer live longer without their cancer returning. About 100 participants will receive durvalumab plus chemo b…
Phase 2 • Sponsor: Qian Chu • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Data model aims to predict lung cancer therapy outcomes
Knowledge-focused Recruiting nowThis study looks at whether a computer model can predict how well non-small cell lung cancer responds to chemotherapy and immunotherapy given before surgery. Researchers will collect data from 500 participants to build and test this prediction tool. The goal is to improve treatme…
Sponsor: Qian Chu • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC